Literature DB >> 11238134

Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia.

C A Tschan1, C Pilz, C Zeidler, K Welte, M Germeshausen.   

Abstract

Point mutations in the granulocyte colony-stimulating factor receptor (G-CSFR) gene have been linked to the development of secondary leukemia in patients with congenital neutropenia (CN). This report presents data on a now 18-year-old patient with CN who has received G-CSF treatment since 1989 and who developed acute myeloid leukemia (AML) in 1998. To evaluate whether there is an association between the occurrence of point mutations of the G-CSFR gene and development of secondary AML, DNA/messenger RNA of neutrophils and mononuclear cells from this patient were analyzed at different time points by polymerase chain reaction and subsequent cloning by DNA sequencing of representative numbers of individual clones. Findings suggest an increasing instability of the G-CSFR gene in time as judged by increasing numbers of mutations proposed to be one important step in the development of AML in this patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238134     DOI: 10.1182/blood.v97.6.1882

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

Review 1.  Severe congenital neutropenias.

Authors:  Julia Skokowa; David C Dale; Ivo P Touw; Cornelia Zeidler; Karl Welte
Journal:  Nat Rev Dis Primers       Date:  2017-06-08       Impact factor: 52.329

Review 2.  Mechanisms of leukemic transformation in congenital neutropenia.

Authors:  Daniel C Link
Journal:  Curr Opin Hematol       Date:  2019-01       Impact factor: 3.284

3.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

Authors:  Philip S Rosenberg; Blanche P Alter; Audrey A Bolyard; Mary Ann Bonilla; Laurence A Boxer; Bonnie Cham; Carol Fier; Melvin Freedman; George Kannourakis; Sally Kinsey; Beate Schwinzer; Connie Zeidler; Karl Welte; David C Dale
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

4.  Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation.

Authors:  Esther van de Vosse; Els M Verhard; Anton J T Tool; Adriëtte W de Visser; Taco W Kuijpers; Pieter S Hiemstra; Jaap T van Dissel
Journal:  Ann Hematol       Date:  2010-08-28       Impact factor: 3.673

5.  Colony-stimulating factor 3 receptor (CSF3R) M696T mutation does not impact on clinical outcomes of a Ph+ acute lymphoblastic leukemia patient.

Authors:  Xin Chen; Bichen Wang; Aiming Pang; Weiping Yuan; Erlie Jiang; Yajing Chu; Sizhou Feng; Mingzhe Han
Journal:  Blood Sci       Date:  2021-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.